Chromosomal translocation products engender new intracellular therapeutic technologies.
Chromosomal translocations occur in leukemias, lymphomas, sarcomas and some epithelial tumors and some generate unique fusion proteins. These translocation products may provide tumor-specific targets for the development of new therapeutic strategies tailored to a malignant cell.
Những tác giả chính: | Rabbitts, T, Stocks, MR |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2003
|
Những quyển sách tương tự
-
Chromosomal translocation master genes, mouse models and experimental therapeutics.
Bằng: Rabbitts, T
Được phát hành: (2001) -
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
Bằng: Pérez-Martínez, D, et al.
Được phát hành: (2010) -
Mouse models of human chromosomal translocations and approaches to cancer therapy.
Bằng: Rabbitts, T, et al.
Được phát hành: (2001) -
The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism.
Bằng: Collins, E, et al.
Được phát hành: (2002) -
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
Bằng: Nam, C, et al.
Được phát hành: (2006)